Skip to content

Healthcare Data News

News from the healthcare data industry

  • Submit News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
Healthcare Data News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
  • Submit News

U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)

Posted on June 9, 2022June 10, 2022Author admin
Category: Collaborations, Competitor News, Oncology Tag: Flatiron Health, Foundation Medicine

Post navigation

Previous PostTempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing
Next PostRutgers Faculty Receives PCORI Contract to Develop Robust Longitudinal Causal Inference Methods with Machine Learning

  • Search by Keyword

  • Reset Filter
  • Search by Category

  • Search by Company and Location

© 2025 Healthcare Data News / Powered by WordPress / Theme by Design Lab